Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30000546 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1427212 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL29253334 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1427215 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1055870 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1039992 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL140696 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL2732862 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL15048699 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL28614760 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892608-B1 | NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS | BRIGHAM & WOMENS HOSPITAL INC (US) | 2025-07-23 | — | — | EP | disclosed |
| EP-4031871-B1 | METHODS FOR PREDICTING PATIENT RESPONSE TO DMARDS | UNIV LONDON QUEEN MARY (GB) | 2024-07-24 | — | — | EP | disclosed |
| CN-114075388-B | Thermosetting release coating agent, cured product, thermosetting release film, and method for producing same | 荒川化学工业株式会社 | 2023-10-20 | — | — | CN | disclosed |
| CN-116693932-A | Regenerated polymer material and method for producing same, cleaning agent and method for producing regenerated polymer | 荒川化学工业株式会社 | 2023-09-05 | — | — | CN | disclosed |
| US-11667598-B2 | N-3 immunoresolvents: structures and actions | THE BRIGHAM & WOMEN'S HOSPITAL INC. (US) | 2023-06-06 | — | — | US | disclosed |
| US-11555006-B2 | Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2023-01-17 | — | — | US | disclosed |
| US-20220349886-A1 | Methods for Predicting Patient Response to DMARDs | QUEEN MARY UNIVERSITY OF LONDON (GB) | 2022-11-03 | — | — | US | disclosed |
| EP-4031871-A1 | METHODS FOR PREDICTING PATIENT RESPONSE TO DMARDS | Queen Mary University of London (GB) | 2022-07-27 | — | — | EP | disclosed |
| CN-114075388-A | Thermosetting release coating agent, cured product, thermosetting release film, and method for producing same | 荒川化学工业株式会社 | 2022-02-22 | — | — | CN | disclosed |
| EP-3892608-A1 | NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS | The Brigham and Women's Hospital, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |
| EP-3103787-A1 | METHOD FOR CHEMICAL CONVERSION OF UNSATURATED FATTY ACID BY CARBON CHAIN EXTENSION REACTION | Bizen Chemical Co., Ltd. (JP) | 2016-12-14 | — | — | EP | disclosed |
| US-20160115112-A1 | NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-04-28 | — | — | US | disclosed |
| EP-3003299-A2 | NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS | The Brigham And Women's Hospital Inc. (US) | 2016-04-13 | — | — | EP | disclosed |
| US-9238634-B2 | Anti-inflammatory metabolite derived from omega-3-type fatty acid | THE UNIVERSITY OF TOKYO (JP) | 2016-01-19 | — | — | US | disclosed |
| WO-2014193652-A2 | NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS | THE BRIGHAM & WOMEN'S HOSPITAL INC. (US) | 2014-12-04 | — | — | WO | disclosed |
| US-8853437-B2 | Anti-inflammatory compounds | THE UNIVERSITY OF TOKYO (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20130274327-A1 | NOVEL ANTI-INFLAMMATORY METABOLITE DERIVED FROM OMEGA-3-TYPE FATTY ACID | THE UNIVERSITY OF TOKYO (JP) | 2013-10-17 | — | — | US | disclosed |
| EP-2607358-A1 | NOVEL ANTI-INFLAMMATORY METABOLITE DERIVED FROM OMEGA-3-TYPE FATTY ACID | The University of Tokyo (JP) | 2013-06-26 | — | — | EP | disclosed |
| US-20120059061-A1 | NOVEL ANTI-INFLAMMATORY COMPOUNDS | THE UNIVERSITY OF TOKYO (JP) | 2012-03-08 | — | — | US | disclosed |
| EP-2415748-A1 | NOVEL ANTI-INFLAMMATORY COMPOUNDS | The University of Tokyo (JP) | 2012-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059061-A1 | NOVEL ANTI-INFLAMMATORY COMPOUNDS | ALOX15, ALOX15B, ALOX12 | FASN 66/4885ALDH1A1 1074/4885TSHR 4542/4885 |
| US-11555006-B2 | Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections | ALOX12, ALOX15, FPR2 | FASN 19/4885ALDH1A1 3891/4885TSHR 4356/4885 |
| US-20160115112-A1 | NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS | ALOX15B, ALOX15, ALOX12 | FASN 14/4885ALDH1A1 1680/4885TSHR 3291/4885 |
| US-20130274327-A1 | NOVEL ANTI-INFLAMMATORY METABOLITE DERIVED FROM OMEGA-3-TYPE FATTY ACID | PTGES3, ALOX5, ALOX15 | FASN 15/4885ALDH1A1 895/4885TSHR 4531/4885 |
| US-11667598-B2 | N-3 immunoresolvents: structures and actions | HPGDS, ALOX5, ALOX15B | FASN 14/4885ALDH1A1 760/4885TSHR 2521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.